Prokidney (PROK) Gains from Sales and Divestitures (2022 - 2025)

Prokidney (PROK) has disclosed Gains from Sales and Divestitures for 4 consecutive years, with $959764.0 as the latest value for Q4 2025.

  • Quarterly Gains from Sales and Divestitures fell 28.19% to $959764.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $959764.0 through Dec 2025, down 28.19% year-over-year, with the annual reading at $959764.0 for FY2025, 28.19% down from the prior year.
  • Gains from Sales and Divestitures for Q4 2025 was $959764.0 at Prokidney, roughly flat from $959764.0 in the prior quarter.
  • The five-year high for Gains from Sales and Divestitures was $2.3 million in Q3 2023, with the low at $949678.0 in Q1 2025.
  • Average Gains from Sales and Divestitures over 4 years is $1.5 million, with a median of $1.3 million recorded in 2024.
  • The sharpest move saw Gains from Sales and Divestitures skyrocketed 65.89% in 2023, then plummeted 41.55% in 2024.
  • Over 4 years, Gains from Sales and Divestitures stood at $1.7 million in 2022, then surged by 30.67% to $2.3 million in 2023, then tumbled by 41.02% to $1.3 million in 2024, then decreased by 28.19% to $959764.0 in 2025.
  • According to Business Quant data, Gains from Sales and Divestitures over the past three periods came in at $959764.0, $959764.0, and $959764.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.